NDC 21695-915 Ak-con
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 21695 - Rebel Distributors Corp.
- 21695-915 - Ak-con
Product Packages
NDC Code 21695-915-15
Package Description: 15 mL in 1 BOTTLE, PLASTIC
Product Details
What is NDC 21695-915?
What are the uses for Ak-con?
Which are Ak-con UNII Codes?
The UNII codes for the active ingredients in this product are:
- NAPHAZOLINE HYDROCHLORIDE (UNII: MZ1131787D)
- NAPHAZOLINE (UNII: H231GF11BV) (Active Moiety)
Which are Ak-con Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- EDETATE DISODIUM (UNII: 7FLD91C86K)
- WATER (UNII: 059QF0KO0R)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- SODIUM CARBONATE (UNII: 45P3261C7T)
- BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)
- HYDROCHLORIC ACID (UNII: QTT17582CB)
- BORIC ACID (UNII: R57ZHV85D4)
What is the NDC to RxNorm Crosswalk for Ak-con?
- RxCUI: 1046272 - naphazoline HCl 0.1 % Ophthalmic Solution
- RxCUI: 1046272 - naphazoline hydrochloride 1 MG/ML Ophthalmic Solution
- RxCUI: 1046272 - naphazoline hydrochloride 0.1 % Ophthalmic Solution
- RxCUI: 1046613 - naphazoline hydrochloride 1 MG/ML Ophthalmic Solution [AK-Con]
- RxCUI: 1046613 - AK-Con 0.1 % Ophthalmic Solution
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".